Monitoring Salivary Levels of Interleukin 1 Beta (IL-1<i>β</i>) and Vascular Endothelial Growth Factor (VEGF) for Two Years of Orthodontic Treatment: A Prospective Pilot Study

<div>Bland-Altman plot comparing the percentage difference of IL-1<i>β</i> and VEGF between baseline and alignment (a), baseline and space closure (b), and baseline and finishing (c). The dotted line represents the upper and lower 95% limits of agreement, and the solid line represents the mean percentage difference between IL-1<i>β</i> and VEGF.</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: Monitoring Salivary Levels of Interleukin 1 Beta (IL-1<i>β</i>) and Vascular Endothelial Growth Factor (VEGF) for Two Years of Orthodontic Treatment: A Prospective Pilot Study 

Figure 2 | Monitoring Salivary Levels of Interleukin 1 Beta (IL-1β) and Vascular Endothelial Growth Factor (VEGF) for Two Years of Orthodontic Treatment: A Prospective Pilot Study 